ContentsMultiple Sclerosis Journal, Volume 23, Issue 3_suppl, Page 1-4, October 2017. … read morePosted At: MS Journal
Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry
Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registryMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Neurodegenerative disease mechanism and potential drug identifiedTwo new studies of neurodegenerative diseases linked to mitochondrial defects offer hope for developing a new biomarker for research and diagnostics, and a drug for treating such diseases....
Sheep disease toxin shines a light on multiple sclerosisA sheep disease has parallels with multiple sclerosis. A study identifies antibodies to the toxin in humans, providing clues as to the condition’s origin. … read...
High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome
High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndromeMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Join Our Mailing List
- MS: Gut bacteria may trigger harmful mechanismPosted At: Medical News Today
- World’s Largest MS Research Conference: Understanding MS and New Strategies to Restore Function
- Conceptual framework to study role of exercise in multiple sclerosis
- Insights into microbiome research 3: Who’s there versus what are they doing?
- Updates From ECTRIMS Research Conference
- Environmental factors may trigger onset of multiple sclerosis
- Genetic Ancestry Associated with Clinical Course in Hispanic-Latinos: Study is Ongoing
- Prognostic information for people with MS: Impossible or inevitable?
- New immunotherapy targeting blood-clotting protein
- Animal models of multiple sclerosis: From rodents to zebrafish